000 | 007430000a22001810004500 | ||
---|---|---|---|
001 | 12382 | ||
090 | _a12382 | ||
100 | _a20090915d k||y0pory50 ba | ||
101 | _aeng | ||
102 | _aUS | ||
200 |
_aMicrobiologic, clinical, and economic outcomes of dual individualized dosing of antimicrobial agents _fJoseph A. Paladino, Jerome J. Schentag |
||
300 | _aCapítulo de monografia | ||
463 |
_aMichael E. Burton... [et al.] _cPhiladelphia _d2006 _e4th ed _nLippincott Williams & Wilkins _pp. 341-353 _tApplied pharmacokinetics and pharmacodynamics : principles of therapeutic drug monitoring _05040 |
||
606 |
_91377 _aFarmacocinética |
||
606 |
_91378 _aFarmacodinâmica |
||
676 |
_a615.7 B98a _v4ª ed. |
||
700 |
_923330 _aPaladino _bJoseph A. |
||
701 |
_926691 _4070 _aSchentag _bJerome J. |
||
942 |
_cANA _n0 |